home / stock / tgtx / tgtx articles

TGTX Articles, TG Therapeutics Inc. - From 07/12/24

Stock Information
Company Name: TG Therapeutics Inc.
Stock Symbol: TGTX
Market: NASDAQ
Website: tgtherapeutics.com
Menu
TGTX TGTX Quote TGTX Short TGTX News TGTX Articles TGTX Message Board
Get TGTX Alerts

News, Short Squeeze, Breakout and More Instantly...
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today | Benzinga

TG Therapeutics (NASDAQ:TGTX) has outperformed the market over the past 5 years by 9.05% on an annualized basis producing an average annual return ...
Insider Transaction: Sagar Lonial Sells $432K Worth Of TG Therapeutics Shares | Benzinga

Disclosed on June 20, Sagar Lonial, Director at TG Therapeutics (NASDAQ:TGTX), executed a substantial insider sell as per the latest SEC filing. Wh...

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company's Chairm...

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference | Benzinga

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that Michael S. Weiss, the Company's Chairm...
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday's session as the company reported first-quarter results and ...

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Wednesday. Shares of Powell Industries, Inc. (NASDAQ:POWL) rose sharply ...

TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update | Benzinga

NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that a conference call will be held tomorrow, ...
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis | Benzinga

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), announced that it has been awarded a national contract with th...

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting | Benzinga

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the presentation of data from the ULTIMATE I &...

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting | Benzinga

NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the schedule of data presentations highlightin...
Previous 10 Next 10